Academic Journal
Transcatheter arterial steroid injection therapy improves the prognosis of patients with acute liver failure
| العنوان: | Transcatheter arterial steroid injection therapy improves the prognosis of patients with acute liver failure |
|---|---|
| المؤلفون: | Kuwano, Akifumi, Okui, Tasuku, Kohjima, Motoyuki, Kurokawa, Miho, Goya, Takeshi, Tanaka, Masatake, Aoyagi, Tomomi, Takahashi, Motoi, Imoto, Koji, Tashiro, Shigeki, Suzuki, Hideo, Fujita, Nobuhiro, Ushijima, Yasuhiro, Ishigami, Kousei, Tokunaga, Shoji, Kato, Masaki, Ogawa, Yoshihiro |
| المصدر: | Medicine ; volume 102, issue 10, page e33090 ; ISSN 0025-7974 |
| بيانات النشر: | Ovid Technologies (Wolters Kluwer Health) |
| سنة النشر: | 2023 |
| الوصف: | Acute liver failure (ALF) is a disorder defined by coagulopathy and encephalopathy with a poor prognosis. No effective therapies have been established except for liver transplantation. We previously reported a subgroup of patients with acute liver injury who developed microcirculatory disturbance. We also established and reported transcatheter arterial steroid injection therapy (TASIT) as a new treatment of ALF. Here, we analyze the effectiveness of TASIT in a larger cohort and evaluate the impact on ALF patients with or without microcirculatory disturbance. We conducted a single-center retrospective study to evaluate the effectiveness of TASIT in patients with ALF admitted at Kyushu University Hospital between January 2005 and March 2018. TASIT is performed by injecting methylprednisolone via the proper hepatic artery for 3 days. One hundred ninety-4 patients with ALF were enrolled and analyzed in this study. Of the 87 patients given TASIT, 71 (81.6%) recovered without any complications and 16 (18.4%) died or underwent liver transplantation. Of the 107 patients not administered TASIT, 77 (72.0%) recovered and 30 (28.0%) progressed to irreversible liver failure. In the high-lactate dehydrogenase subgroup, 52 (86.7%) of the 60 patients with TASIT recovered, and the survival rate was significantly higher than that in patients who did not receive TASIT. Multivariate regression analysis revealed that the TASIT procedure was one of the significant prognostic factors in the high-lactate dehydrogenase subgroup and was significantly associated with prothrombin activity percentage improvement. TASIT is an effective treatment for patients with ALF, especially in those with microcirculatory disturbance. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1097/md.0000000000033090 |
| DOI: | 10.1097/MD.0000000000033090 |
| الاتاحة: | http://dx.doi.org/10.1097/md.0000000000033090 https://journals.lww.com/10.1097/MD.0000000000033090 |
| Rights: | http://creativecommons.org/licenses/by-nc/4.0/ |
| رقم الانضمام: | edsbas.5BF73D33 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1097/md.0000000000033090 |
|---|